Page last updated: 2024-11-05

thalidomide and Sterility, Female

thalidomide has been researched along with Sterility, Female in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, L1
Liu, Y1
Li, J1
Liu, Q1
Liu, B1
Shi, X1

Reviews

1 review available for thalidomide and Sterility, Female

ArticleYear
Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis.
    Medicine, 2023, Mar-17, Volume: 102, Issue:11

    Topics: Female; Humans; Infertility, Female; Inflammatory Bowel Diseases; Ovarian Reserve; Reproduction; Tha

2023